RYDAPT_RYDAPT_HEMATOLOGY
Drug
Novartis Pharma AG
Total Payments
$24,594
Transactions
19
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $24,594 | 19 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $13,650 | 1 | 55.5% |
| Travel and Lodging | $10,944 | 18 | 44.5% |
Top Doctors Receiving Payments for RYDAPT_RYDAPT_HEMATOLOGY
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MBBS | Hematology & Oncology | Houston, TX | $24,594 | 19 |
Ad
Manufacturing Companies
- Novartis Pharma AG $24,594
Product Information
- Type Drug
- Total Payments $24,594
- Total Doctors 1
- Transactions 19
About RYDAPT_RYDAPT_HEMATOLOGY
RYDAPT_RYDAPT_HEMATOLOGY is a drug associated with $24,594 in payments to 1 healthcare providers, recorded across 19 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2019 to 2019. In 2019, $24,594 was paid across 19 transactions to 1 doctors.
The most common payment nature for RYDAPT_RYDAPT_HEMATOLOGY is "Consulting Fee" ($13,650, 55.5% of total).